Drug and Medication Analysis & Statistics, October 2014 (p4)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

91-120 of about 4 400 reports

Purchase Reports From Reputable Market Research Publishers

Smoking Cessation - Pipeline Review, H2 2014

Smoking Cessation - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Smoking Cessation - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Smoking Cessation - Pipeline Review, H2 2014', provides an overview of the Smoking Cessation's therapeutic pipeline. This ...

  • Industries : Drug and Medication
  • Countries : World
Neuroendocrine Tumors - Pipeline Review, H2 2014

Neuroendocrine Tumors - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Neuroendocrine Tumors - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Neuroendocrine Tumors - Pipeline Review, H2 2014', provides an overview of the Neuroendocrine Tumors's therapeutic pipeline. ...

  • Industries : Drug and Medication
  • Countries : World, United States
Male Hypogonadism - Pipeline Review, H2 2014

Male Hypogonadism - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Male Hypogonadism - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Male Hypogonadism - Pipeline Review, H2 2014', provides an overview of the Male Hypogonadism's therapeutic pipeline. This ...

  • Industries : Drug and Medication
  • Countries : World
Anesthetic Effect - Pipeline Review, H2 2014

Anesthetic Effect - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Anesthetic Effect - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Anesthetic Effect - Pipeline Review, H2 2014', provides an overview of the Anesthetic Effect's therapeutic pipeline. This ...

  • Industries : Drug and Medication
  • Countries : World
Antibiotics Partnering Terms and Agreements

Antibiotics Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • January 2015
  • by Currentpartnering

The Antibiotics Partnering Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in antibiotics ...

  • Industries : Drug and Medication
Infectious Vaccines Partnering Terms and Agreements

Infectious Vaccines Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • January 2015
  • by Currentpartnering

The Infectious Vaccines Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals ...

  • Industries : Drug and Medication
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400

Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400

  • $ 1 995
  • Industry report
  • December 2014
  • by Plunkett Research

Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 Vital industry-specific data ...

  • Industries : Drug and Medication
  • Countries : United States
Cancer Vaccine Partnering Terms and Agreements

Cancer Vaccine Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • December 2014
  • by Currentpartnering

The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends ...

  • Industries : Drug and Medication
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

  • $ 1 995
  • Industry report
  • December 2014
  • by Global Data

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and ...

  • Industries : Drug and Medication
  • Countries : Denmark
Global and China Lithium Carbonate Industry Report, 2014

Global and China Lithium Carbonate Industry Report, 2014

  • $ 1 900
  • Industry report
  • December 2014
  • by Research In China

Global lithium carbonate output grew by 10.57% year on year to 144,400 tons in 2013, and, driven by downstream demand, will maintain an upward momentum, with an estimated AAGR of around 10% over the next ...

  • Industries : Drug and Medication
  • Countries : China
Oral Thin Films Market, 2015 - 2025

Oral Thin Films Market, 2015 - 2025

  • $ 1 899
  • Industry report
  • January 2015
  • by Roots Analysis Private Ltd.

INTRODUCTION Oral drug delivery technologies form an integral part of the pharmaceutical industry. From the conventional tablets / capsules to modern-day fast disintegrating and rapidly acting tablets ...

  • Industries : Drug and Medication
Novel Drug Reconstitution Systems Market, 2014 - 2024

Novel Drug Reconstitution Systems Market, 2014 - 2024

  • $ 1 899
  • Industry report
  • December 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION In today's pharmaceutical market, many drugs are supplied in powdered formulation because of their lower shelf life in liquid formulation. The drugs are formulated into powdered form by various ...

  • Industries : Drug and Medication
Breast Cancer Drug Pathway Analyzer 2015

Breast Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 567 targeted molecular therapies known to affect more than 256 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Colorectal Cancer Drug Pathway Analyzer 2015

Colorectal Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 399 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Lung Cancer Drug Pathway Analyzer 2015

Lung Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 548 targeted molecular therapies known to affect more than 257 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Prostate Cancer Drug Pathway Analyzer 2015

Prostate Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 413 targeted molecular therapies known to affect more than 249 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Hematological Cancers Drug Pathway Analyzer 2015

Hematological Cancers Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 767 targeted molecular therapies known to affect more than 259 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Renal Cancer Drug Pathway Analyzer 2015

Renal Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 238 targeted molecular therapies known to affect more than 240 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Ovarian Cancer Drug Pathway Analyzer 2015

Ovarian Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 349 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Pancreatic Cancer Drug Pathway Analyzer 2015

Pancreatic Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 325 targeted molecular therapies known to affect more than 252 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Brain Cancer Drug Pathway Analyzer 2015

Brain Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 245 targeted molecular therapies known to affect more than 239 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Gastrointestinal Cancer Drug Pathway Analyzer 2015

Gastrointestinal Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 203 targeted molecular therapies known to affect more than 239 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Conjugated Drugs in Oncology: Drug Pathway Analyzer 2015

Conjugated Drugs in Oncology: Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 306 conjugated drugs known to affect more than 209 specific intracellular signaling pathways for the treatment ...

  • Industries : Drug and Medication
Brain Cancer Drug Pipeline Update 2015

Brain Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Despite the heavy investment made into brain cancer research, primary brain cancer, with glioblastoma multiforme being the most aggressive and most common form, remains one of the most deadly diseases ...

  • Industries : Drug and Medication
Breast Cancer Drug Pipeline Update 2015

Breast Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. Despite recent drug approvals in the adjuvant and metastatic setting, ...

  • Industries : Drug and Medication
Cancer Vaccines Drug Pipeline Update 2015

Cancer Vaccines Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has ...

  • Industries : Drug and Medication
Colorectal Cancer Drug Pipeline Update 2015

Colorectal Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of Avastin ...

  • Industries : Drug and Medication
Head and Neck Cancer Drug Pipeline Update 2015

Head and Neck Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

There are today 149 companies plus partners developing 168 drugs targeting head and neck cancer in development. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs ove ...

  • Industries : Drug and Medication
Lung Cancer Drug Pipeline Update 2015

Lung Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two decades of extensive R&D ...

  • Industries : Drug and Medication
Ovarian Cancer Drug Pipeline Update 2015

Ovarian Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means small and therefore it remains an important secondary indication for existing ...

  • Industries : Drug and Medication

61 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Abbott Laboratories

United States

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.